Davide Giuseppe Ribaldone

113PUBLICATIONS
263CO-AUTHORS
Food properties (incl. characteristics and health benefits)Environmental epidemiologyInnate immunityRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (113)

|Aug 13, 2026
Long-Term Feasibility, Adherence, and Exploratory Clinical Outcomes of Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition in Adults with Crohn's Disease.

|Jul 15, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.

|Mar 14, 2026
Sampling Extension, Chronic Infiltrates, and Eosinophils: Support for the Evaluation of Histological Healing in Inflammatory Bowel Disease with Endoscopic Remission.

Gabriella Canavese, Enrico Costantino Falco, Davide Giuseppe Ribaldone

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Feb 13, 2026
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.

Davide Scalvini, Stiliano Maimaris, Elisa Stasi

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

Pageof 19

Frequent Collaborators

46 joint publications

Gian Paolo Caviglia

42 joint publications

Giorgio Saracco

27 joint publications

Angelo Armandi

19 joint publications

Chiara Rosso